Viking Therapeutics (VKTX) News Today → Trump Asset Seizure Threat Alert: Could Your Savings Be Next? (From American Hartford Gold Group) (Ad) Free VKTX Stock Alerts $79.91 +0.30 (+0.38%) (As of 05/8/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineBiotech Breakthroughs: 7 Stocks Driving the Next Wave in Healthcareinvestorplace.com - May 7 at 2:04 PMAmgen, newer rivals could threaten Novo Nordisk and Eli Lilly's weight loss drug dominancecnbc.com - May 7 at 11:33 AMViking Therapeutics (NASDAQ:VKTX) Stock Price Down 3.5% on Insider Sellingamericanbankingnews.com - May 7 at 1:34 AMLisanti Capital Growth LLC Makes New $6.49 Million Investment in Viking Therapeutics, Inc. (NASDAQ:VKTX)marketbeat.com - May 6 at 10:14 PMViking Therapeutics, Inc. (NASDAQ:VKTX) is favoured by institutional owners who hold 72% of the companyfinance.yahoo.com - May 6 at 10:08 AMEli Lilly Gains on the GLP-1 Weight Loss Phenomenon (VKTX)marketbeat.com - May 6 at 6:15 AMGreg Zante Sells 66,756 Shares of Viking Therapeutics, Inc. (NASDAQ:VKTX) Stockamericanbankingnews.com - May 5 at 4:18 AMInsider Selling: Viking Therapeutics, Inc. (NASDAQ:VKTX) CFO Sells 66,756 Shares of Stockinsidertrades.com - May 4 at 7:27 AMMarianna Mancini Sells 281,425 Shares of Viking Therapeutics, Inc. (NASDAQ:VKTX) Stockamericanbankingnews.com - May 4 at 4:04 AMViking Therapeutics, Inc. (NASDAQ:VKTX) CFO Greg Zante Sells 66,756 Sharesmarketbeat.com - May 3 at 10:18 PMViking Therapeutics, Inc. (NASDAQ:VKTX) COO Marianna Mancini Sells 281,425 Sharesinsidertrades.com - May 3 at 6:41 AMWhat Is the Best Weight Loss Stock to Buy Now? Our Top 3 Picksinvestorplace.com - May 2 at 6:49 PMViking Therapeutics (NASDAQ:VKTX) Shares Down 2.1% marketbeat.com - May 2 at 3:23 PMJFG Wealth Management LLC Makes New Investment in Viking Therapeutics, Inc. (NASDAQ:VKTX)marketbeat.com - May 2 at 11:39 AMViking Therapeutics, Inc. (NASDAQ:VKTX) Given Average Rating of "Buy" by Brokeragesamericanbankingnews.com - May 2 at 2:22 AMViking Therapeutics (NASDAQ:VKTX) Trading Down 4%marketbeat.com - May 1 at 1:59 PMHere's How Much You Would Have Made Owning Viking Therapeutics Stock In The Last 5 Yearsbenzinga.com - May 1 at 1:12 PMStock Market Crash Alert: 3 Must-Buy Biotech Stocks When Prices Plungeinvestorplace.com - May 1 at 11:59 AMViking Therapeutics Delivers Smaller-Than-Expected Q1 Lossfool.com - April 30 at 5:05 PMViking Therapeutics (NASDAQ:VKTX) Stock Price Up 1%marketbeat.com - April 30 at 3:38 PMViking Therapeutics (NASDAQ:VKTX) Shares Up 0.6%marketbeat.com - April 29 at 3:18 PMQ4 2024 Earnings Forecast for Viking Therapeutics, Inc. (NASDAQ:VKTX) Issued By Leerink Partnrsamericanbankingnews.com - April 29 at 4:02 AMQ2 2024 Earnings Estimate for Viking Therapeutics, Inc. Issued By HC Wainwright (NASDAQ:VKTX)americanbankingnews.com - April 29 at 1:40 AMViking Therapeutics, Inc. to Post Q2 2024 Earnings of ($0.17) Per Share, William Blair Forecasts (NASDAQ:VKTX)americanbankingnews.com - April 29 at 1:40 AMIs Viking Therapeutics Incredibly Undervalued?fool.com - April 28 at 10:30 AMCan This High-Flying Stock 10x in 10 Years?fool.com - April 28 at 9:07 AMViking Therapeutics (NASDAQ:VKTX) Trading Down 0.3%marketbeat.com - April 26 at 6:32 PMViking Therapeutics Reports Q1 Results: 'An Exceptional Period' Says CEOmsn.com - April 26 at 8:33 AMBuy Rating Affirmed for Viking Therapeutics Amidst Strong Clinical Progress and Strategic Movesmarkets.businessinsider.com - April 26 at 8:33 AMViking Therapeutics, Inc. (NASDAQ:VKTX) Q1 2024 Earnings Call Transcriptfinance.yahoo.com - April 26 at 8:33 AMViking Therapeutics (NASDAQ:VKTX) Stock Price Up 1.6% on Strong Earningsmarketbeat.com - April 25 at 12:06 PMViking Therapeutics (NASDAQ:VKTX) Announces Earnings Resultsmarketbeat.com - April 25 at 11:05 AMViking Therapeutics (NASDAQ:VKTX) Given Buy Rating at HC Wainwrightmarketbeat.com - April 25 at 8:09 AMVKTX Stock Earnings: Viking Therapeutics Beats EPS for Q1 2024investorplace.com - April 24 at 11:13 PMViking Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Updatefinance.yahoo.com - April 24 at 4:29 PMViking Therapeutics (NASDAQ:VKTX) Stock Price Up 1.8%marketbeat.com - April 24 at 4:22 PM3 Biotech Stocks With Skyrocketing Potential: April 2024investorplace.com - April 24 at 11:36 AM3 Red-Hot Biotech Rockets Blasting Off in 2024investorplace.com - April 24 at 8:00 AMViking Therapeutics (NASDAQ:VKTX) Shares Up 4.6%marketbeat.com - April 23 at 2:58 PMBetter Buy: Pfizer vs. Viking Therapeuticsfool.com - April 23 at 9:15 AM3 Stocks With the Potential to Surpass Analyst Expectations for 2024msn.com - April 23 at 7:44 AMViking Therapeutics (NASDAQ:VKTX) Shares Down 0.7% marketbeat.com - April 22 at 2:32 PMViking Therapeutics, Inc. (NASDAQ:VKTX) Shares Purchased by Knights of Columbus Asset Advisors LLCmarketbeat.com - April 22 at 6:24 AMWegovy vs. Zepbound: Who Wins the Battle of the GLP-1 Drugs?marketbeat.com - April 22 at 6:05 AMWegovy vs. Zepbound: Who Wins the Battle of the GLP-1 Drugs? (VKTX)marketbeat.com - April 22 at 6:05 AMViking Therapeutics (NASDAQ:VKTX) Shares Down 2.2% marketbeat.com - April 19 at 12:45 PMViking Therapeutics (NASDAQ:VKTX) Stock Price Down 2%marketbeat.com - April 18 at 2:47 PMViking Therapeutics (NASDAQ:VKTX) Stock Price Down 0%marketbeat.com - April 17 at 12:42 PMLLY, VKTX, or NVO: Which Weight-Loss Drugmaker Could Gain the Best Returns?msn.com - April 17 at 3:24 AMViking Therapeutics (NASDAQ:VKTX) Trading Up 1.9%marketbeat.com - April 16 at 1:40 PM Get Viking Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for VKTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Did You Get Your Free Bitcoin Yet? (Ad)And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin. >> Register right here VKTX Media Mentions By Week VKTX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VKTX News Sentiment▼0.620.36▲Average Medical News Sentiment VKTX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VKTX Articles This Week▼167▲VKTX Articles Average Week Get Viking Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for VKTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Roivant Sciences News Today Ascendis Pharma A/S News Today Legend Biotech News Today Cerevel Therapeutics News Today Catalent News Today Jazz Pharmaceuticals News Today Intra-Cellular Therapies News Today United Therapeutics News Today Elanco Animal Health News Today Cytokinetics News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:VKTX) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaDems have chosen Biden replacement?Paradigm PressThis 1 Biotech Stock has been shocking the marketsHuge AlertsThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldHe Is Giving Away BitcoinCrypto Swap ProfitsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersTrump Asset Seizure Threat Alert: Could Your Savings Be Next?American Hartford Gold GroupUrgent Nvidia WarningAltimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Viking Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
